# EmboMedics, Inc.: Form D filings

EmboMedics, Inc., a biotechnology company in Minneapolis, MN, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on October 25, 2017, reports $740,775 sold of a $1.3 million offering to 12 investors.

Find out what EmboMedics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EmboMedics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EmboMedics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fembomedics-inc-1592901)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EmboMedics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EmboMedics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fembomedics-inc-1592901)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 678 Mendelssohn Ave. N., Minneapolis, MN, 55427
- Phone: (763) 398-5120
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1592901

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 25, 2017 | New notice | $1,300,000 | $740,775 | $559,225 | 12 | Sep 20, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1592901/000120919117057933/0001209191-17-057933-index.htm) |
| Apr 7, 2016 | Amendment | $4,287,938 | $4,287,938 | $0 | 29 | Jul 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1592901/000120919116113641/0001209191-16-113641-index.htm) |
| Aug 14, 2014 | New notice | $5,000,000 | $846,750 | $4,153,250 | 9 | Jul 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1592901/000118143114029189/0001181431-14-029189-index.htm) |
| Feb 3, 2014 | New notice | $860,000 | $860,000 | $0 | 15 | Jun 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1592901/000118143114004686/0001181431-14-004686-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jafar Golzarian | Director, Promoter |  |
| Robert Cohen | Executive Officer, Director |  |
| Robert Halverson | Director |  |
| Gerald D. Van Eeckhout | Director |  |
| Reza Malek | Director |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of Oct 23, 2017](https://specstream.ai/data/form-d/week/2017-10-23) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what EmboMedics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).